ByTrending Posts
Can This AI-Driven Biotech Duo Cut Biologic Development…
Key Highlights • AI-driven protein production from Axio BioPharma integrates with Likarda’s Core-Shell Spherification® (CSS®) delivery platform to…
95 Pathologists, 11 Hospitals, 1 AI Platform: Can…
Key Takeaways• 95 pathologists across 11 hospitals to adopt PathAI’s AISight® digital pathology platform, enabling real-time, AI-enhanced diagnostics•…
How Are the 2025 MedTech Breakthrough Awards Shaping…
Key Highlights: 1. TrustCommerce and Waystar: Leaders in Healthcare Payments InnovationTrustCommerce, a Sphere Company, has been honored with…
How Peerbridge Health’s AI-Powered Cardiac Wearable Clinched the…
Key Highlights AI-Driven Innovation Revolutionizing Cardiac Diagnostics: Peerbridge Health’s Peerbridge Cor® is the first AI-powered wearable bringing hospital-grade…
How Xsolis’ AI-Driven Dragonfly Clinched the 2025 MedTech’s…
Key Highlights Xsolis Sets New Standard in AI-Powered Clinical EfficiencyTennessee-based AI tech firm Xsolis has won top honors…
25 AI-Driven Companies Leading, Top the 2025 Transformation:…
Key Highlights AI-First Innovation Is No Longer Optional—It’s the Industry Standard The 2025 MedTech leaderboard showcases how artificial…
How AccurKardia’s Award-Winning AccurECG™ Platform Redefine ECG Diagnostics…
Key Highlights: A Landmark Recognition for a Game-Changing ECG Technology AccurKardia’s AccurECG™ has been named the “Best New…
Can MIT and Recursion’s New AI Model Boltz-2…
Key Takeaways• Boltz-2 delivers AI-driven binding affinity predictions 1000x faster than traditional free energy methods—dramatically accelerating virtual screening…
Is Optic and Mechanica’s AI Venture Model the…
Key Highlights Strategic Collaboration to Power AI-Led Biotech GrowthOptic, Inc., a pioneer in AI platforms for biopharma, has…
Trending Posts
Latest Stories
Could Immix Biopharma’s Strategic Investment by Goose Capital Accelerate Breakthrough CAR-T Therapies for AL Amyloidosis?
Key Highlights: Strategic Investment Signals Confidence in Immix’s Mission Immix Biopharma (Nasdaq: IMMX), a clinical-stage…
Is Novartis’ $1.4 Billion Acquisition of Tourmaline Bio a Game-Changer for Cardiovascular Inflammation Therapies?
Key Highlights A $1.4 Billion Bet on Cardiovascular Innovation Novartis announced its agreement to acquire…
Could GE HealthCare’s FDA-Cleared Revolution™ Vibe CT System Usher in a New Era of AI-Powered Cardiac Imaging?
Key Highlights Revolutionizing Cardiac Imaging with One-Beat ClarityGE HealthCare’s Revolution Vibe CT system has received…
Could Merck and Daiichi Sankyo’s 48% Response Rate with Ifinatamab Deruxtecan Redefine Treatment for Small Cell Lung Cancer?
Key Highlights Promising Phase 2 Data Signals Breakthrough PotentialResults from the IDeate-Lung01 trial demonstrated compelling…
Gallery
